Condition
Movement Disorders (Incl Parkinsonism)
Total Trials
5
Recruiting
2
Active
2
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed2
Recruiting2
Enrolling By Invitation1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07056348Not ApplicableRecruiting
Long-term Brain Stimulation of the Motor Ventral Thalamus (VOP/VIM) to Improve Motor Function
NCT07056361Not ApplicableRecruitingPrimary
Stimulating Specific Brain Areas (VOP/VIM) With Electricity to Improve Movement and Muscle Control
NCT05462080CompletedPrimary
Correlation of Motor Metrics and Neurological Data
NCT06283043Enrolling By InvitationPrimary
Effect of Motor Function, Depression and Sleep Quality on Attention in Parkinson's Disease
NCT01547481CompletedPrimary
MRI Study of Brain Activity in Healthy Adults and Individuals With Parkinsonism and Rapid Eye Movement Disorder.
Showing all 5 trials